AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HAYES, C. W.
Right arrow Articles by KILLEN, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HAYES, C. W.
Right arrow Articles by KILLEN, D. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 97, 755-761, Copyright © 1966 by American Roentgen Ray Society

EXPERIMENTAL EVALUATION OF CONCENTRATED SOLUTIONS OF IOTHALAMIC ACID DERIVATIVES AS ANGIOGRAPHIC CONTRAST MEDIA

CAULEY W. HAYES M.D.1, JOHN H. FOSTER M.D.1, ROBERT SEWELL B.S.1, and DUNCAN A. KILLEN M.D.1

1 From the S.R. Light Laboratory for Surgical Research, The Surgical Research Laboratory, Veterans Administration Hospital, and the Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee

Two new concentrated contrast agents, MP 1005.2 and MP 2032, which are derivatives of iothalamic acid have been tested as angiographic contrast media. The results have been compared to results obtained with hypaque M-90; both of the new media proved to be less neurotoxic and nephrotoxic. Thus, in equivalent solutions iothalamate salts proved to be less toxic than the diatrizoate salts. The intravenous tolerance of these media was far better than with hypaque M-90. MP 2032 is far too viscous for use as a concentrated medium—it may find usefulness as a less concentrated contrast agent. MP 1005.2 is sufficiently impressive to warrant trial as an aortographic medium—especially in thoracic aortography.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
T.R. Marshall
Clinical Evaluation of Vascoray (Sodium Iothalamate 26%/Methylglucamine Iothalamate 52%) a New Contrast Medium
Angiology, May 1, 1973; 24(5): 288 - 296.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1966 by the American Roentgen Ray Society.